MC1R and melanoma: Specifically, individuals who were homozygous for MC1R mutant alleles had a significantly lower risk of melanoma-specific death in a series of 3060 cases from Europe and the United States (HR, 0.78; 95% CI, 0.65–0.94), implying that a functional MC1R pathway promotes melanoma progression in humans.